Kristopher W. Krausz

Gut microbiota and intestinal FXR mediate the clinical benefits of metformin

Lulu Sun, Cen Xie, Guang Wang et al. · Nature Medicine · 2018 · 1K citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +13

Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity

Fei Li, Changtao Jiang, Kristopher W. Krausz et al. · Nature Communications · 2013 · 690 citations · Full text

Life Sciences, Cell Biology, Pharmacology +14

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

Changtao Jiang, Cen Xie, Fei Li et al. · Journal of Clinical Investigation · 2014 · 675 citations · Full text

Life Sciences, Nutrition, Pharmacology +15

Intermittent Fasting Promotes White Adipose Browning and Decreases Obesity by Shaping the Gut Microbiota

Guolin Li, Cen Xie, Siyu Lu et al. · Cell Metabolism · 2017 · 653 citations · Full text

Life Sciences, Nutritional Sciences, Physiology +14

Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism

Preeti Pathak, Cen Xie, Robert G. Nichols et al. · Hepatology · 2018 · 538 citations · Full text

Life Sciences, Endocrinology, Pharmacology +17